Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Insmed Incorporated(INSM) | 750,000 | 1,600,000 | +850,000 | $50.25M | $116.80M | 9.22% | +$66.55M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 1,500,000 | 900,000 | -600,000 | $160.09M | $100.27M | 7.91% | -$59.83M |
| Cytokinetics, Incorporated(CYTK) | 2,075,000 | 1,500,000 | -575,000 | $112.42M | $79.20M | 6.25% | -$33.22M |
| Inari Medical Inc | 350,000 | 1,550,000 | +1,200,000 | $16.85M | $63.92M | 5.04% | +$47.07M |
| Arcellx Inc COMMON STOCK | 675,000 | 675,000 | 0 | $37.25M | $56.37M | 4.45% | +$19.12M |
| Structure Therapeutics IncADS | 560,000 | 1,150,000 | +590,000 | $21.99M | $50.47M | 3.98% | +$28.48M |
| KalVista Pharmaceuticals Inc | 2,300,000 | 4,000,000 | +1,700,000 | $27.09M | $46.32M | 3.65% | +$19.23M |
| Astria Therapeutics Inc | 3,250,000 | 4,000,000 | +750,000 | $29.57M | $44.04M | 3.47% | +$14.46M |
| Immatics N.V.SHS(IMTX) | 2,750,000 | 3,750,000 | +1,000,000 | $31.95M | $42.79M | 3.38% | +$10.83M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 1,800,000 | 750,000 | -1,050,000 | $73.98M | $41.66M | 3.29% | -$32.32M |
| Ascendis Pharma A/SADR(ASND) | 750,000 | 250,000 | -500,000 | $102.28M | $37.33M | 2.95% | -$64.96M |
| Soleno Therapeutics Inc | 1,200,000 | 720,000 | -480,000 | $48.96M | $36.35M | 2.87% | -$12.61M |
| Day One Biopharmaceuticals Inc COM | 1,250,000 | 2,500,000 | +1,250,000 | $17.23M | $34.83M | 2.75% | +$17.60M |
| Savara Inc.(SVRA) | 6,490,000 | 8,090,000 | +1,600,000 | $26.15M | $34.30M | 2.71% | +$8.15M |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 760,000 | +760,000 | $0 | $33.77M | 2.66% | +$33.77M |
| Xenon Pharmaceuticals Inc.(XENE) | 525,000 | 825,000 | +300,000 | $20.47M | $32.48M | 2.56% | +$12.01M |
| BioMarin Pharmaceutical Inc.(BMRN) | 0 | 400,000 | +400,000 | $0 | $28.12M | 2.22% | +$28.12M |
| uniQure N.V.SHS(QURE) | 4,750,000 | 4,750,000 | 0 | $21.28M | $23.42M | 1.85% | +$2.14M |
| Janux Therapeutics, Inc.(JANX) | 725,000 | 485,000 | -240,000 | $30.37M | $22.03M | 1.74% | -$8.34M |
| Black Diamond Therapeutics Inc | 2,100,000 | 5,028,500 | +2,928,500 | $9.79M | $21.87M | 1.73% | +$12.09M |
| Solid Biosciences Inc | 2,665,000 | 2,800,000 | +135,000 | $15.11M | $19.52M | 1.54% | +$4.41M |
| Edwards Lifesciences Corp | 0 | 275,000 | +275,000 | $0 | $18.15M | 1.43% | +$18.15M |
| Gilead Sciences, Inc.(GILD) | 0 | 200,000 | +200,000 | $0 | $16.77M | 1.32% | +$16.77M |
| Liquidia Corporation(LQDA) | 1,830,000 | 1,500,000 | -330,000 | $21.96M | $15.00M | 1.18% | -$6.96M |
| Agilent Technologies, Inc.(A) | 0 | 100,000 | +100,000 | $0 | $14.85M | 1.17% | +$14.85M |
| Bristol-Myers Squibb Company(BMY) | 500,000 | 250,000 | -250,000 | $20.77M | $12.94M | 1.02% | -$7.83M |
| GSK plcADR(GSK) | 0 | 300,000 | +300,000 | $0 | $12.26M | 0.97% | +$12.26M |
| Bicara Therapeutics Inc | 0 | 425,000 | +425,000 | $0 | $10.82M | 0.85% | +$10.82M |
| Dianthus Therapeutics, Inc.(DNTH) | 600,000 | 395,000 | -205,000 | $15.53M | $10.82M | 0.85% | -$4.71M |
| Crinetics Pharmaceuticals Inc | 0 | 205,000 | +205,000 | $0 | $10.48M | 0.83% | +$10.48M |
| iTeos Therapeutics Inc | 1,750,000 | 1,025,000 | -725,000 | $25.97M | $10.47M | 0.83% | -$15.50M |
| Applied Therapeutics Inc | 5,430,000 | 1,145,000 | -4,285,000 | $25.36M | $9.73M | 0.77% | -$15.63M |
| Nurix Therapeutics, Inc.(NRIX) | 500,000 | 425,000 | -75,000 | $10.44M | $9.55M | 0.75% | -$885.3K |
| SanofiADR(SNY) | 0 | 150,000 | +150,000 | $0 | $8.64M | 0.68% | +$8.64M |
| Bruker Corporation(BRKR) | 0 | 125,000 | +125,000 | $0 | $8.63M | 0.68% | +$8.63M |
| Apogee Therapeutics Inc | 0 | 136,500 | +136,500 | $0 | $8.02M | 0.63% | +$8.02M |
| Zymeworks Inc.(ZYME) | 440,000 | 615,000 | +175,000 | $3.74M | $7.72M | 0.61% | +$3.97M |
| Lexeo Therapeutics, Inc.(LXEO) | 840,000 | 850,000 | +10,000 | $13.47M | $7.68M | 0.61% | -$5.79M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 0 | 230,000 | +230,000 | $0 | $7.56M | 0.60% | +$7.56M |
| Alto Neuroscience, Inc.(ANRO) | 620,000 | 650,000 | +30,000 | $6.63M | $7.44M | 0.59% | +$808.2K |
| Becton, Dickinson and Company(BDX) | 0 | 30,000 | +30,000 | $0 | $7.23M | 0.57% | +$7.23M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 30,000 | +30,000 | $0 | $6.37M | 0.50% | +$6.37M |
| Legend Biotech CorporationADS(LEGN) | 0 | 125,000 | +125,000 | $0 | $6.09M | 0.48% | +$6.09M |
| Fate Therapeutics, Inc.(FATE) | 2,000,000 | 1,685,000 | -315,000 | $6.56M | $5.90M | 0.47% | -$662.5K |
| Lakefront Biotherapeutics NVADR(LKFT) | 180,000 | 180,000 | 0 | $4.46M | $5.18M | 0.41% | +$721.8K |
| UroGen Pharma Ltd.(URGN) | 0 | 400,000 | +400,000 | $0 | $5.08M | 0.40% | +$5.08M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 890,000 | 930,000 | +40,000 | $3.33M | $4.93M | 0.39% | +$1.60M |
| Geron Corporation(GERN) | 0 | 1,050,000 | +1,050,000 | $0 | $4.77M | 0.38% | +$4.77M |
| Passage Bio, Inc.(PASG) | 6,052,000 | 6,100,000 | +48,000 | $4.81M | $4.27M | 0.34% | -$536.5K |
| Allogene Therapeutics Inc | 2,200,000 | 1,500,000 | -700,000 | $5.13M | $4.20M | 0.33% | -$926.0K |
| Prime Medicine, Inc.(PRME) | 450,000 | 1,070,000 | +620,000 | $2.31M | $4.14M | 0.33% | +$1.83M |
| Ventyx Biosciences Inc | 1,315,000 | 1,725,000 | +410,000 | $3.04M | $3.76M | 0.30% | +$722.9K |
| Zevra Therapeutics, Inc.(ZVRA) | 0 | 525,000 | +525,000 | $0 | $3.64M | 0.29% | +$3.64M |
| Ardelyx Inc | 0 | 500,000 | +500,000 | $0 | $3.44M | 0.27% | +$3.44M |
| PTC Therapeutics, Inc.(PTCT) | 90,000 | 80,000 | -10,000 | $2.75M | $2.97M | 0.23% | +$215.8K |
| Penumbra, Inc.(PEN) | 0 | 15,000 | +15,000 | $0 | $2.91M | 0.23% | +$2.91M |
| Voyager Therapeutics, Inc.(VYGR) | 600,000 | 490,000 | -110,000 | $4.75M | $2.87M | 0.23% | -$1.88M |
| MacroGenics, Inc.(MGNX) | 800,000 | 830,000 | +30,000 | $3.40M | $2.73M | 0.22% | -$669.3K |
| Verve Therapeutics Inc | 500,000 | 525,000 | +25,000 | $2.44M | $2.54M | 0.20% | +$101.0K |
| Intra-Cellular Therapies Inc | 0 | 30,000 | +30,000 | $0 | $2.20M | 0.17% | +$2.20M |
| Establishment Labs Holdings Inc.(ESTA) | 0 | 40,000 | +40,000 | $0 | $1.73M | 0.14% | +$1.73M |
| Relmada Therapeutics, Inc.(RLMD) | 1,200,000 | 490,000 | -710,000 | $3.60M | $1.59M | 0.13% | -$2.01M |
| Achilles Therapeutics PLCADS | 1,500,000 | 1,500,000 | 0 | $1.22M | $1.53M | 0.12% | +$307.5K |
| Reneo Pharmaceuticals Inc | 545,000 | 799,400 | +254,400 | $823.0K | $1.36M | 0.11% | +$536.0K |
| Chimerix Inc | 1,400,000 | 1,400,000 | 0 | $1.23M | $1.30M | 0.10% | +$75.6K |
| Atara Biotherapeutics Inc | 112,000 | 124,677 | +12,677 | $952.0K | $1.01M | 0.08% | +$61.6K |
| Tenax Therapeutics, Inc.(TENX) | 0 | 83,333 | +83,333 | $0 | $288.3K | 0.02% | +$288.3K |
| ALX Oncology Holdings Inc.(ALXO) | 3,600,000 | 0 | -3,600,000 | $21.71M | $0 | — | -$21.71M |
| Apellis Pharmaceuticals Inc COM | 335,000 | 0 | -335,000 | $12.85M | $0 | — | -$12.85M |
| Axsome Therapeutics, Inc.(AXSM) | 300,000 | 0 | -300,000 | $24.15M | $0 | — | -$24.15M |
| BeOne Medicines AGADR(ONC) | 350,000 | 0 | -350,000 | $49.93M | $0 | — | -$49.93M |
| BioNTech SEADS(BNTX) | 100,000 | 0 | -100,000 | $8.04M | $0 | — | -$8.04M |
| Denali Therapeutics Inc.(DNLI) | 500,000 | 0 | -500,000 | $11.61M | $0 | — | -$11.61M |
| Dyne Therapeutics, Inc.(DYN) | 225,000 | 0 | -225,000 | $7.94M | $0 | — | -$7.94M |
| Endeavour Silver Corp.(EXK) | 925,000 | 0 | -925,000 | $39.08M | $0 | — | -$39.08M |
| Fulcrum Therapeutics, Inc.(FULC) | 1,160,000 | 0 | -1,160,000 | $7.19M | $0 | — | -$7.19M |
| Globus Medical, Inc.CL A(GMED) | 900,000 | 0 | -900,000 | $61.64M | $0 | — | -$61.64M |
| Immunome, Inc.(IMNM) | 1,000,000 | 0 | -1,000,000 | $12.10M | $0 | — | -$12.10M |
| Inspire Medical Systems, Inc.(INSP) | 60,000 | 0 | -60,000 | $8.03M | $0 | — | -$8.03M |
| Iovance Biotherapeutics, Inc.(IOVA) | 300,000 | 0 | -300,000 | $2.41M | $0 | — | -$2.41M |
| Newamsterdam Pharma Co NV ORDINARY SHARES | 25,000 | 0 | -25,000 | $480.3K | $0 | — | -$480.3K |
| Pacira BioSciences, Inc.(PCRX) | 280,000 | 0 | -280,000 | $8.01M | $0 | — | -$8.01M |
| Praxis Precision Medicines, Inc.(PRAX) | 440,000 | 0 | -440,000 | $18.20M | $0 | — | -$18.20M |